This Article Full Text Full Text (PDF) All Versions of this Article: 35/9/2024    most recent 01.STR.0000137765.64705.d8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Apfalter, P. Articles by Hirschl, A. M. Search for Related Content PubMed PubMed Citation Articles by Apfalter, P. Articles by Hirschl, A. M. Related Collections Pathophysiology Risk Factors Other diagnostic testing Carotid Stenosis

(Stroke. 2004;35:2024.)
© 2004 American Heart Association, Inc.

Original Contributions

No Evidence of Involvement of Chlamydia pneumoniae in Severe Cerebrovascular Atherosclerosis by Means of Quantitative Real-Time Polymerase Chain Reaction

Petra Apfalter, MD; Wolfgang Barousch, BSc; Marion Nehr; Birgit Willinger, MD; Manfred Rotter, MD Alexander M. Hirschl, MD

From the Department of Clinical Microbiology, Institute of Hygiene and Medical Microbiology, Medical University of Vienna, Austria.

Correspondence to Dr Petra Apfalter, Department of Clinical Microbiology, Institute of Hygiene and Medical Microbiology, National Reference Laboratory for Chlamydia pneumoniae, Vienna University Hospital, Waehringer Guertel 18-20/5P, 1090 Vienna, Austria. E-mail petra.apfalter{at}meduniwien.ac.at

Background and Purpose— All studies reporting high numbers of Chlamydia pneumoniae DNA positives in stroke patients published to date have used polymerase chain reaction (PCR) techniques highly prone to generate false-positive results. The aim of this study was to analyze the prevalence of C. pneumoniae DNA in plaques of the carotid artery as well as in peripheral blood by means of a new, closed, real-time PCR system.

Methods— Carotid endarterectomy specimens and preoperative peripheral blood mononuclear cells (PBMC) of 75 individuals with severe cerebrovascular atherosclerosis were analyzed by means of a C. pneumoniae-specific quantitative ompA-based real-time PCR TaqMan system. Plaques were also cultured onto HEp-2 cells. Before the surgical intervention, C. pneumoniae-specific IgM, IgG, and IgA as well as C-reactive protein (CRP) levels were determined.

Results— 89% of all patients studied had C. pneumoniae-specific antibodies, but the pathogen was not detected in a single carotid atheroma by real-time PCR and cell culture. However, C. pneumoniae DNA was detected in 4 PBMC samples (5.3%) at very low levels (<1 inclusion/6 mL EDTA blood). No statistical significance was found between symptomatic/asymptomatic patients, C. pneumoniae PCR, results and CRP values after correction for multiplicity-of-test adjustment.

Conclusions— By means of a closed, highly sensitive, and specific real-time PCR, C. pneumoniae was not detected in cerebrovascular atherosclerosis. PCR on PBMC was not predictive for endovascular chlamydia infection and most likely stem from previous C. pneumoniae respiratory tract infection in individual cases.

Key Words: Chlamydia pneumoniae • polymerase chain reaction • senile plaques • stroke

This article has been cited by other articles:

				A. J. Littman, L. A. Jackson, and T. L. Vaughan Chlamydia pneumoniae and Lung Cancer: Epidemiologic Evidence Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 773 - 778. [Abstract] [Full Text] [PDF]